NextPlat (NXPL) Corporate presentation summary

Business overview

• Operates globally in healthcare and technology, offering pharmacy, data management, and e-commerce solutions across 150+ countries.

• Serves 60,000+ customers, including governments, military, and humanitarian organizations.

• Listed on Nasdaq with 2.7 million shares outstanding and a $17.1 million market cap as of May 2026.

• Generated $54.3 million in revenue for 2025, with $13.7 million in cash at year-end.

Strategic focus and turnaround

• Refocused on high-growth healthcare and e-commerce sectors, expanding leadership and efficiency programs.

• Shifted from retail pharmacy to high-margin contracted offerings, targeting 340B and long-term care entities.

• Expanded healthcare services from Florida to all 50 states and grew e-commerce internationally.

• Reduced annualized overhead by over $2 million and staff by 25%, driving margin improvements.

Operational and financial performance

• Achieved 20%+ gross margin growth in Q1 2026 and expects profitability in 2026.

• New 340B contracts and high-margin prescription volumes exceeded 8,000 per month.

• Q1 2026 gross margin projected to exceed 34%, with operating expenses down 8% from Q4 2025.

• Ended 2025 with $13.7 million in cash and no long-term debt.